Goldman Sachs
MBOT icon

Goldman Sachs’s Microbot Medical MBOT Stock Holding History

Goldman Sachs’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$745K Buy
309,103
+274,640
+797% +$613K ﹤0.01% 5309
2025
Q4 		$68.9K Buy
+34,463
New +$81.6K ﹤0.01% 6252
2025
Q3 		– Sell
-34,003
Closed -$85.7K – 6534
2025
Q2 		$85.7K Sell
34,003
-3,741
-10% -$8.95K ﹤0.01% 5845
2025
Q1 		$57K Buy
+37,744
New +$66.7K ﹤0.01% 5868
2017
Q2 		– Sell
-1,104
Closed -$96K – 6872
2017
Q1 		$96K Buy
+1,104
New +$96.9K ﹤0.01% 6078
2016
Q3 		– Sell
-113
Closed -$6K – 7115
2016
Q2 		$6K Buy
+113
New +$32.6K ﹤0.01% 6918
2014
Q4 		– Sell
-49
Closed -$101K – 7226
2014
Q3 		$101K Buy
49
+40
+444% +$106K ﹤0.01% 6576
2014
Q2 		$28K Buy
+9
New +$20.8K ﹤0.01% 6839

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Goldman Sachs's MBOT Position: Q1 2026 in Review

Goldman Sachs increased its Microbot Medical (MBOT) stake by 797% in Q1 2026, buying an estimated $613K and bringing the position to 309,103 shares worth $745K. The position accounts for ﹤0.01% of the portfolio, ranked #5309.

Goldman Sachs first reported a position in MBOT in Q2 2014 and has held it in 8 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Goldman Sachs held 309,103 shares of Microbot Medical worth $745K as of Q1 2026.
  • Goldman Sachs bought 274,640 Microbot Medical shares in Q1 2026, an estimated $613K.
  • Microbot Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5309 holding.
  • Goldman Sachs first reported a position in Microbot Medical in Q2 2014 and has held it in 8 quarters since.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.